The "Global Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.
Global digital respiratory solutions market will reach $319.3 million by 2030, growing by 36.2% annually over 2020-2030 driven by the rising demand for air filtration amid COVID-19 pandemic.
Highlighted with 84 tables and 76 figures, this 164-page report Global Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global digital respiratory solutions market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
Key Players
- 3M Health Care Limited
- Adherium Limited
- Amiko Digital Health Limited
- AsthmaMD
- AstraZeneca plc
- Boehringer Ingelheim International GmbH
- Capsule Technologies, Inc.
- Cohero Health
- GlaxoSmithKline plc
- Kaia Health Software GmbH
- Medical International Research (MIR)
- Novartis AG
- NuvoAir
- Reciprocal Labs (Propeller Health)
- Sensiron AG
- Tactio Health
- Teva Pharmaceuticals Industries Ltd.
Key Topics Covered:
1 Introduction
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter's Five Forces Analysis
3 Segmentation of Global Market by Product Type
3.1 Market Overview by Product Type
3.2 Therapeutic Devices
3.2.1 Inhalers
3.2.2 Nebulizers
3.3 Diagnostic Devices
3.3.1 Spirometers
3.3.2 Asthma Monitors
3.3.3 Other Diagnostic Devices
3.4 Sensors and Apps
4 Segmentation of Global Market by Indication
4.1 Market Overview by Indication
4.2 Asthma
4.3 Chronic Obstructive Pulmonary Disease (COPD)
4.4 COVID-19 Caused Diseases
4.5 Other Diseases
5 Segmentation of Global Market by Distribution Channel
5.1 Market Overview by Distribution Channel
5.2 Hospital Pharmacies
5.3 Retail Pharmacies
5.4 Online Pharmacies
6 Segmentation of Global Market by Region
6.1 Geographic Market Overview 2019-2030
6.2 North America Market 2019-2030 by Country
6.2.1 Overview of North America Market
6.2.2 U.S.
6.2.3 Canada
6.2.4 Mexico
6.3 European Market 2019-2030 by Country
6.3.1 Overview of European Market
6.3.2 Germany
6.3.3 UK
6.3.4 France
6.3.5 Spain
6.3.6 Italy
6.3.7 Russia
6.3.8 Rest of European Market
6.4 Asia-Pacific Market 2019-2030 by Country
6.4.1 Overview of Asia-Pacific Market
6.4.2 Japan
6.4.3 China
6.4.4 Australia
6.4.5 India
6.4.6 South Korea
6.4.7 Rest of APAC Region
6.5 South America Market 2019-2030 by Country
6.5.1 Argentina
6.5.2 Brazil
6.5.3 Chile
6.5.4 Rest of South America Market
6.6 MEA Market 2019-2030 by Country
6.6.1 UAE
6.6.2 Saudi Arabia
6.6.3 South Africa
6.6.4 Other National Markets
7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
8 Investing in Global Market: Risk Assessment and Management
8.1 Risk Evaluation of Global Market
8.2 Critical Success Factors (CSFs)
For more information about this report visit https://www.researchandmarkets.com/r/gva63v
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200810005573/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
